BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25300172)

  • 21. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.
    Arechabala MC; Catoni MI; Claro JC; Rojas NP; Rubio ME; Calvo MA; Letelier LM
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010597. PubMed ID: 29611180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flushing the central venous catheter: is heparin necessary?
    Dal Molin A; Allara E; Montani D; Milani S; Frassati C; Cossu S; Tonella S; Brioschi D; Rasero L
    J Vasc Access; 2014; 15(4):241-8. PubMed ID: 24811598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of heparin versus 0.9% saline solution in maintaining the permeability of central venous catheters: a systematic review].
    Santos EJ; Nunes MM; Cardoso DF; Apóstolo JL; Queirós PJ; Rodrigues MA
    Rev Esc Enferm USP; 2015 Dec; 49(6):999-1007. PubMed ID: 27419685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for restoring patency of occluded central venous catheter lumens.
    van Miert C; Hill R; Jones L
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007119. PubMed ID: 22513946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis.
    Almeida BM; Moreno DH; Vasconcelos V; Cacione DG
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013554. PubMed ID: 35363884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review.
    Mitchell MD; Anderson BJ; Williams K; Umscheid CA
    J Adv Nurs; 2009 Oct; 65(10):2007-21. PubMed ID: 20568318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation for patients with cancer and central venous catheters.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006468. PubMed ID: 21491394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation for patients with cancer and central venous catheters.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006468. PubMed ID: 21328283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of different flushing and locking techniques on catheter occlusion rates in central venous catheters: protocol for a multicentre, randomized controlled, parallel-group, open-label, superiority clinical trial.
    Li R; Zhou M; Sun L; Sha L; Xu B; Li T; Tao T; Yuan L
    Trials; 2024 Jun; 25(1):380. PubMed ID: 38867301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic lock for the prevention of catheter-related infection in neonates.
    Taylor JE; Tan K; Lai NM; McDonald SJ
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010336. PubMed ID: 26040840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin for prolonging peripheral intravenous catheter use in neonates.
    Shah PS; Ng E; Sinha AK
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002774. PubMed ID: 16235300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
    Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants.
    McMullan RL; Gordon A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012181. PubMed ID: 29512818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters.
    McCann M; Moore ZE
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006894. PubMed ID: 20091610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.